Abstract
Protein phosphatase 2A (PP2A) is one of the major protein serine/threonine phosphatases (PPPs) with regulatory effects on several cellular processes, but its role and function in Adriamycin (ADR)-treated podocytes injury needs to be further explored. Mice podocytes were treated with ADR and PP2A inhibitor (okadaic acid, OA). After transfection, cell apoptosis was detected by flow cytometry. Expressions of podocytes injury-, apoptosis- and epithelial-to-mesenchymal transition (EMT)- and JNK-interacting protein 4/p38-Mitogen-Activated Protein Kinase (JIP4/p38-MAPK) pathway-related factors were measured using quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot as needed. Interaction between PP2A and JIP4/MAPK pathway was confirmed using co-immunoprecipitation (Co-Ip) assay. In podocytes, ADR inhibited PP2A, Nephrin and Wilms’ tumor (WT) 1 expressions yet upregulated apoptosis and Desmin expression, and suppressing PP2A expressionenhanced the effects. PP2A overexpression reversed the effects of ADR on PP2A and podocyte injury-related factors expressions and apoptosis of podocytes. JIP4 was the candidate gene interacting with both PP2A and p38-MAPK pathway, and PP2A overexpression alleviated the effects of ADR on p38-MAPK pathway-related factors expressions. Additionally, in ADR-treated podocytes, PP2A suppression enhanced the effects of ADR, yet silencing of JIP4 reversed the effects of PP2A suppression on regulating p38-MAPK pathway-, apoptosis- and EMT-related factors expressions and apoptosis, with upregulations of B-cell lymphoma-2 (Bcl-2) and E-cadherin and down-regulations of Bcl-2 associated protein X (Bax), cleaved (C)-casapse-3, N-cadherin, Vimentin and Snail. PP2A protects ADR-treated podocytes against injury and EMT by suppressing JIP4/p38-MAPK pathway, showing their interaction in podocytes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akankwasa G, Jianhua L, Guixue C, Changjuan A, Xiaosong Q (2018) Urine markers of podocyte dysfunction: a review of podocalyxin and nephrin in selected glomerular diseases. Biomark Med 12:927–935. https://doi.org/10.2217/bmm-2018-0152
Asakawa S et al (2017) Podocyte injury and albuminuria in experimental hyperuricemic model rats. Oxid Med Cell Longev 2017:3759153. https://doi.org/10.1155/2017/3759153
Asfahani RI et al (2018) Activation of podocyte Notch mediates early Wt1 glomerulopathy. Kidney Int 93:903–920. https://doi.org/10.1016/j.kint.2017.11.014
Baskaran R, Velmurugan BK (2018) Protein phosphatase 2A as therapeutic targets in various disease models. Life Sci 210:40–46. https://doi.org/10.1016/j.lfs.2018.08.063
Brys R, Gibson K, Poljak T, Van Der Plas S, Amantini D (2020) Discovery and development of ASK1 inhibitors. Prog Med Chem 59:101–179. https://doi.org/10.1016/bs.pmch.2020.02.001
Chen C et al (2018) Autophagy and doxorubicin resistance in cancer. Anticancer Drugs 29:1–9. https://doi.org/10.1097/cad.0000000000000572
Chen C, Nelson LJ, Ávila MA, Cubero FJ (2019a) Mitogen-activated protein kinases (MAPKs) and cholangiocarcinoma: the missing link. Cells. https://doi.org/10.3390/cells8101172
Chen Y, Lin L, Tao X, Song Y, Cui J, Wan J (2019b) The role of podocyte damage in the etiology of ischemia-reperfusion acute kidney injury and post-injury fibrosis. BMC Nephrol 20:106. https://doi.org/10.1186/s12882-019-1298-x
Cristóbal I, Torrejón B, Martínez-Useros J, Madoz-Gurpide J, Rojo F, García-Foncillas J (2017) PP2A regulates signaling through hormonal receptors in breast cancer with important therapeutic implications. Biochim Biophys Acta 1868:435–438. https://doi.org/10.1016/j.bbcan.2017.08.005
Dolka I, Król M, Sapierzyński R (2016) Evaluation of apoptosis-associated protein (Bcl-2, Bax, cleaved caspase-3 and p53) expression in canine mammary tumors: an immunohistochemical and prognostic study. Res Vet Sci 105:124–133. https://doi.org/10.1016/j.rvsc.2016.02.004
Edlich F (2018) BCL-2 proteins and apoptosis: recent insights and unknowns. Biochem Biophys Res Commun 500:26–34. https://doi.org/10.1016/j.bbrc.2017.06.190
Enjoji S et al (2018) Stemness is enhanced in gastric cancer by a SET/PP2A/E2F1 axis. Mol Cancer Res MCR 16:554–563. https://doi.org/10.1158/1541-7786.mcr-17-0393
Gao J, Zheng Q, Shao Y, Wang W, Zhao C (2018) CD155 downregulation synergizes with adriamycin to induce breast cancer cell apoptosis. Apoptosis Int J Program Cell Death 23:512–520. https://doi.org/10.1007/s10495-018-1473-8
Glassock RJ, Warnock DG, Delanaye P (2017) The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol 13:104–114. https://doi.org/10.1038/nrneph.2016.163
Huang Z et al (2016) Cdc42 deficiency induces podocyte apoptosis by inhibiting the Nwasp/stress fibers/YAP pathway. Cell Death Dis 7:e2142. https://doi.org/10.1038/cddis.2016.51
Huang SS et al (2017) Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy. Sci Rep 7:45692. https://doi.org/10.1038/srep45692
Jaca A, Govender P, Locketz M, Naidoo R (2017) The role of miRNA-21 and epithelial mesenchymal transition (EMT) process in colorectal cancer. J Clin Pathol 70:331–356. https://doi.org/10.1136/jclinpath-2016-204031
Kauko O, Westermarck J (2018) Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer. Int J Biochem Cell Biol 96:157–164. https://doi.org/10.1016/j.biocel.2018.01.005
Lee J, An JN, Hwang JH, Lee H, Lee JP, Kim SG (2019) p38 MAPK activity is associated with the histological degree of interstitial fibrosis in IgA nephropathy patients. PLoS One 14:e0213981. https://doi.org/10.1371/journal.pone.0213981
Li G, Li CX, Xia M, Ritter JK, Gehr TW, Boini K, Li PL (2015) Enhanced epithelial-to-mesenchymal transition associated with lysosome dysfunction in podocytes: role of p62/Sequestosome 1 as a signaling hub. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol 35:1773–1786. https://doi.org/10.1159/000373989
Li R et al (2018) JLP-JNK signaling protects cancer cells from reactive oxygen species-induced cell death. Biochem Biophys Res Commun 501:724–730. https://doi.org/10.1016/j.bbrc.2018.05.055
Li C, Guan XM, Wang RY, Xie YS, Zhou H, Ni WJ, Tang LQ (2020) Berberine mitigates high glucose-induced podocyte apoptosis by modulating autophagy via the mTOR/P70S6K/4EBP1 pathway. Life Sci 243:117277. https://doi.org/10.1016/j.lfs.2020.117277
Li W, Luo L, Shi W, Yin Y, Gao S (2021) Ursolic acid reduces Adriamycin resistance of human ovarian cancer cells through promoting the HuR translocation from cytoplasm to nucleus. Environ Toxicol 36:267–275. https://doi.org/10.1002/tox.23032
Liu M et al (2017) Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. Nat Commun 8:413. https://doi.org/10.1038/s41467-017-00498-4
Liu X et al (2018) Leonurine ameliorates adriamycin-induced podocyte injury via suppression of oxidative stress. Free Radic Res 52:952–960. https://doi.org/10.1080/10715762.2018.1500021
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif) 25:402–408. https://doi.org/10.1006/meth.2001.1262
Loeffler I, Wolf G (2014) Transforming growth factor-β and the progression of renal disease. Nephrol Dial Transpl Off Publ Eur Dial Transpl Assoc Eur Ren Assoc 29:i37–i45. https://doi.org/10.1093/ndt/gft267
Luo R, Yang K, Wang F, Xu C, Yang T (2020) (Pro)renin receptor decoy peptide PRO20 protects against adriamycin-induced nephropathy by targeting the intrarenal renin-angiotensin system. Am J Physiol Renal Physiol 319:F930–F940. https://doi.org/10.1152/ajprenal.00279.2020
Ma F, Wang SH, Cai Q, Zhang MD, Yang Y, Ding J (2016) Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer. Biomed Pharmacother = Biomedecine pharmacotherapie 84:1249–1255. https://doi.org/10.1016/j.biopha.2016.10.064
Mallipattu SK, He JC (2016) The podocyte as a direct target for treatment of glomerular disease? Am J Physiol Ren Physiol 311:F46–F51. https://doi.org/10.1152/ajprenal.00184.2016
Martin CE, Jones N (2018) Nephrin signaling in the podocyte: an updated view of signal regulation at the slit diaphragm and beyond. Front Endocrinol 9:302. https://doi.org/10.3389/fendo.2018.00302
Muqbil I, Wu J, Aboukameel A, Mohammad RM, Azmi AS (2014) Snail nuclear transport: the gateways regulating epithelial-to-mesenchymal transition? Semin Cancer Biol 27:39–45. https://doi.org/10.1016/j.semcancer.2014.06.003
Nader CP, Cidem A, Verrills NM, Ammit AJ (2019) Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer. Respir Res 20:222. https://doi.org/10.1186/s12931-019-1192-x
Ni Y et al (2018) Plectin protects podocytes from adriamycin-induced apoptosis and F-actin cytoskeletal disruption through the integrin α6β4/FAK/p38 MAPK pathway. J Cell Mol Med 22:5450–5467. https://doi.org/10.1111/jcmm.13816
Pal M, Bhattacharya S, Kalyan G, Hazra S (2018) Cadherin profiling for therapeutic interventions in Epithelial Mesenchymal Transition (EMT) and tumorigenesis. Exp Cell Res 368:137–146. https://doi.org/10.1016/j.yexcr.2018.04.014
Persak H, Pitzschke A (2013) Tight interconnection and multi-level control of Arabidopsis MYB44 in MAPK cascade signalling. PLoS One 8:e57547. https://doi.org/10.1371/journal.pone.0057547
Pinder A, Loo D, Harrington B, Oakes V, Hill MM, Gabrielli B (2015) JIP4 is a PLK1 binding protein that regulates p38MAPK activity in G2 phase. Cell Signal 27:2296–2303. https://doi.org/10.1016/j.cellsig.2015.08.009
Raij L, Tian R, Wong JS, He JC, Campbell KN (2016) Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress. Am J Physiol Ren Physiol 311:F1308–F1317. https://doi.org/10.1152/ajprenal.00162.2016
Ramos F, Villoria MT, Alonso-Rodríguez E, Clemente-Blanco A (2019) Role of protein phosphatases PP1, PP2A, PP4 and Cdc14 in the DNA damage response. Cell Stress 3:70–85. https://doi.org/10.15698/cst2019.03.178
Reynhout S, Janssens V (2019) Physiologic functions of PP2A: lessons from genetically modified mice. Biochim Biophys Acta Mol Cell Res 1866:31–50. https://doi.org/10.1016/j.bbamcr.2018.07.010
Romoli S et al (2018) CXCL12 blockade preferentially regenerates lost podocytes in cortical nephrons by targeting an intrinsic podocyte-progenitor feedback mechanism. Kidney Int 94:1111–1126. https://doi.org/10.1016/j.kint.2018.08.013
Roomi MW, Kalinovsky T, Roomi NW, Rath M, Niedzwiecki A (2014) Prevention of Adriamycin-induced hepatic and renal toxicity in male BALB/c mice by a nutrient mixture. Exp Ther Med 7:1040–1044. https://doi.org/10.3892/etm.2014.1535
Roy S, Roy S, Rana A, Akhter Y, Hande MP, Banerjee B (2018) The role of p38 MAPK pathway in p53 compromised state and telomere mediated DNA damage response. Mutat Res Genet Toxicol Environ Mutagen 836:89–97. https://doi.org/10.1016/j.mrgentox.2018.05.018
Strouhalova K, Přechová M, Gandalovičová A, Brábek J, Gregor M, Rosel D (2020) Vimentin intermediate filaments as potential target for cancer treatment. Cancers. https://doi.org/10.3390/cancers12010184
Su J et al (2017) Regulation of stomatal immunity by interdependent functions of a pathogen-responsive MPK3/MPK6 cascade and abscisic acid. Plant Cell 29:526–542. https://doi.org/10.1105/tpc.16.00577
Tanaka T, Iino M, Goto K (2014) Knockdown of Sec8 enhances the binding affinity of c-Jun N-terminal kinase (JNK)-interacting protein 4 for mitogen-activated protein kinase kinase 4 (MKK4) and suppresses the phosphorylation of MKK4, p38, and JNK, thereby inhibiting apoptosis. FEBS J 281:5237–5250. https://doi.org/10.1111/febs.13063
Tang Z, Takahashi Y (2018) Analysis of protein–protein interaction by Co-IP in human cells. Methods Mol Biol (Clifton, NJ) 1794:289–296. https://doi.org/10.1007/978-1-4939-7871-7_20
Taskin E et al (2020) Silencing HMGB1 expression inhibits adriamycin’s heart toxicity via TLR4 dependent manner through MAPK signal transduction. J BUON Off J Balk Union Oncol 25:554–565
Tobisawa T et al (2017) Insufficient activation of Akt upon reperfusion because of its novel modification by reduced PP2A-B55α contributes to enlargement of infarct size by chronic kidney disease. Basic Res Cardiol 112:31. https://doi.org/10.1007/s00395-017-0621-6
Vilela F et al (2019) Structural characterization of the RH1-LZI tandem of JIP3/4 highlights RH1 domains as a cytoskeletal motor-binding motif. Sci Rep 9:16036. https://doi.org/10.1038/s41598-019-52537-3
Wang DX et al (2017) Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3beta/beta-catenin signaling pathways. Acta Pharmacol Sin 38:241–251. https://doi.org/10.1038/aps.2016.122
Willett R, Martina JA, Zewe JP, Wills R, Hammond GRV, Puertollano R (2017) TFEB regulates lysosomal positioning by modulating TMEM55B expression and JIP4 recruitment to lysosomes. Nat Commun 8:1580. https://doi.org/10.1038/s41467-017-01871-z
Wu SY et al (2019) Penfluridol triggers cytoprotective autophagy and cellular apoptosis through ROS induction and activation of the PP2A-modulated MAPK pathway in acute myeloid leukemia with different FLT3 statuses. J Biomed Sci 26:63. https://doi.org/10.1186/s12929-019-0557-2
Yi M et al (2017) Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy. Am J Physiol Ren Physiol 313:F74–F84. https://doi.org/10.1152/ajprenal.00114.2017
Yu J et al (2016) mPGES-1-derived PGE2 contributes to adriamycin-induced podocyte injury. Am J Physiol Ren Physiol 310:F492–F498. https://doi.org/10.1152/ajprenal.00499.2015
Zhang H, Ren R, Du J, Sun T, Wang P, Kang P (2017) AF1q contributes to adriamycin-induced podocyte injury by activating Wnt/β-catenin signaling. Kidney Blood Press Res 42:794–803. https://doi.org/10.1159/000484329
Zhang P, Fang J, Zhang J, Ding S, Gan D (2020) Curcumin inhibited podocyte cell apoptosis and accelerated cell autophagy in diabetic nephropathy via regulating Beclin1/UVRAG/Bcl2. Diabetes Metab Syndr Obes Targets Ther 13:641–652. https://doi.org/10.2147/dmso.s237451
Zhu X et al (2019) Protein phosphatase 2A modulates podocyte maturation and glomerular functional integrity in mice. Cell Commun Signal 17:91. https://doi.org/10.1186/s12964-019-0402-y
Funding
This work was supported by the Key Research and Development Plan of Zhejiang Province [2019C03028]; the National Natural Foundation of China [81770710].
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lu, Z., Zhu, X., Ye, Y. et al. PP2A protects podocytes against Adriamycin-induced injury and epithelial-to-mesenchymal transition via suppressing JIP4/p38-MAPK pathway. Cytotechnology 73, 697–713 (2021). https://doi.org/10.1007/s10616-021-00484-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-021-00484-1